Search This Blog

Monday, June 11, 2018

Senseonics initiated with a Buy at Craig-Hallum


Craig-Hallum analyst Alexander Nowak started Senseonics with a Buy rating and $6.50 price target while noting that its novel continuous glucose monitor is nearing FDA approval and a largely untapped $23B market opportunity awaits.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)